Cencora, Inc. (COR) company profile

Cencora, Inc. sources and distributes brand-name, specialty, and generic pharmaceuticals, over-the-counter medications, and home healthcare supplies for human and animal health. The company also provides commercialization, consulting, packaging, pharmacy automation, and specialty logistics solutions. It operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. Customers include health systems, acute care hospitals, retail and mail-order pharmacies, medical clinics, physician practices, veterinarians, and biopharmaceutical manufacturers.

The company maintains a global presence across the United States, Europe, Canada, and select international markets, supported by a network of distribution centers including a national facility in Columbus, Ohio. Its workforce exceeds 51,000 employees worldwide, with approximately 41% based in the United States. The company is incorporated in Delaware, and the provided text does not specify the city or state of its headquarters.

Summary of the business section of Cencora's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of September 30, 2025, we had more than 51,000 employees globally, of which approximately 47,000 were full-time employees and approximately 41% were U.S.-based employees.”